Dear Sir,

We read with interest your recent article entitled “The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy”1.We would like to discuss another blood-derived source at potential risk for SARS-CoV-2 transmission that is represented by homologous products applied as eye drops for the treatment of severe corneal diseases. Since the use of these products in ophthalmic practice is increasing, and the duration of the pandemic is currently unpredictable, we believe this issue is worthy of consideration. [ … ]



Giuseppe Giannaccare - Department of Ophthalmology, “Magna Graecia” University, Catanzaro

Marina Buzzi - Emilia Romagna Cord Blood Bank Transfusion Service, “S. Orsola-Malpighi” Teaching Hospital, Bologna

Piera Versura - Ophthalmology Unit, “S. Orsola-Malpighi” Teaching Hospital, University of Bologna, Bologna, Italy

  • Abstract viewed - 298 times
  • PDF downloaded - 12 times